We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ELAB market cap is 1.08B. The company's latest EPS is USD -0.0083 and P/E is -251.81.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD ($) | USD ($) | |||
Total Revenue | 555k | 698k | 615k | 605k |
Operating Income | -1.33M | -1.08M | -1.68M | -1.41M |
Net Income | -784k | -1.16M | -1.4M | -1.41M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 766k | 1.71M |
Operating Income | -1.27M | -3.76M |
Net Income | -1.8M | -4.3M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD ($) | USD ($) | |||
Total Assets | 1.58M | 5.19M | 4.23M | 5.08M |
Total Liabilities | 1.75M | 1.36M | 1.74M | 2.44M |
Total Equity | -164k | 3.83M | 2.49M | 2.64M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 1.89M | 5.19M |
Total Liabilities | 761k | 1.36M |
Total Equity | 1.13M | 3.83M |
Market Cap | 1.08B |
Price to Earnings Ratio | -251.81 |
Price to Sales Ratio | 633.33 |
Price to Cash Ratio | 326.56 |
Price to Book Ratio | 282.71 |
Dividend Yield | - |
Shares Outstanding | 517.66M |
Average Volume (1 week) | 1.35M |
Average Volume (1 Month) | 305.89M |
52 Week Change | -99.58% |
52 Week High | 778.00 |
52 Week Low | 1.7402 |
Spread (Intraday) | 0.05 (2.39%) |
Company Name | Elevai Labs Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://elevailabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions